[go: up one dir, main page]

AU2001247227A1 - 2-thioether a2a receptor agonists - Google Patents

2-thioether a2a receptor agonists

Info

Publication number
AU2001247227A1
AU2001247227A1 AU2001247227A AU4722701A AU2001247227A1 AU 2001247227 A1 AU2001247227 A1 AU 2001247227A1 AU 2001247227 A AU2001247227 A AU 2001247227A AU 4722701 A AU4722701 A AU 4722701A AU 2001247227 A1 AU2001247227 A1 AU 2001247227A1
Authority
AU
Australia
Prior art keywords
thioether
receptor agonists
agonists
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001247227A
Inventor
Gloria Cristalli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gilead Palo Alto Inc
Original Assignee
CV Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CV Therapeutics Inc filed Critical CV Therapeutics Inc
Publication of AU2001247227A1 publication Critical patent/AU2001247227A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001247227A 2000-02-23 2001-02-22 2-thioether a2a receptor agonists Abandoned AU2001247227A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US18447500P 2000-02-23 2000-02-23
US60184475 2000-02-23
US09733196 2000-12-08
US09/733,196 US20010051612A1 (en) 2000-02-23 2000-12-08 2-Thioether A2A receptor agonists
PCT/US2001/005854 WO2001062768A1 (en) 2000-02-23 2001-02-22 2-thioether a2a receptor agonists

Publications (1)

Publication Number Publication Date
AU2001247227A1 true AU2001247227A1 (en) 2001-09-03

Family

ID=26880162

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001247227A Abandoned AU2001247227A1 (en) 2000-02-23 2001-02-22 2-thioether a2a receptor agonists

Country Status (3)

Country Link
US (1) US20010051612A1 (en)
AU (1) AU2001247227A1 (en)
WO (1) WO2001062768A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005020286D1 (en) * 2004-05-26 2010-05-12 Inotek Pharmaceuticals Corp PURE DERIVATIVES THAN ADENOSINE A 1 RECEPTOR AGONISTS AND METHOD FOR THE APPLICATION THEREOF
BRPI0515506A (en) * 2004-09-20 2008-07-29 Inotek Pharmaceuticals Corp purine derivatives and methods of use thereof
AU2006320578B2 (en) * 2005-11-30 2013-01-31 Inotek Pharmaceuticals Corporation Purine derivatives and methods of use thereof
US20070183995A1 (en) * 2006-02-09 2007-08-09 Conopco, Inc., D/B/A Unilever Compounds useful as agonists of A2A adenosine receptors, cosmetic compositions with A2A agonists and a method for using the same
US9132130B2 (en) 2009-04-28 2015-09-15 Zenyaku Kogyo Kabushiki Kaisha Purine derivative and antitumor agent using same
AU2010266313A1 (en) 2009-06-30 2012-01-19 Forest Laboratories Holdings Limited Alkoxy-carbonyl-amino-alkynyl-adenosine compounds and derivatives thereof as A2A R agonists
EA025415B1 (en) 2010-01-11 2016-12-30 Инотек Фармасьютикалз Корпорейшн Combination, kit and method of reducing intraocular pressure
EP2569325A4 (en) 2010-03-26 2013-10-09 Inotek Pharmaceuticals Corp METHOD FOR REDUCING INTRAOCULAR PRESSURE IN HUMANS USING N6-CYCLOPENTYLADENOSINE (CPA) DERIVATIVES OR CPA PRODRUGS
US9278991B2 (en) 2012-01-26 2016-03-08 Inotek Pharmaceuticals Corporation Anhydrous polymorphs of [(2R,3S,4R,5R)-5-(6-(cyclopentylamino)-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)} methyl nitrate and processes of preparation thereof
CA2903114A1 (en) 2013-03-15 2014-09-25 Inotek Pharmaceuticals Corporation Ophthalmic formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2331223C2 (en) * 1972-06-19 1984-11-22 Kohjin Co., Ltd., Tokio / Tokyo S-substituted-2-thioadenosines, their 5'-monophosphates, processes for their preparation and pharmaceuticals containing them
US3968102A (en) * 1974-04-18 1976-07-06 Kohjin Co., Ltd. S-substituted-2-thioadenosines
GB9414193D0 (en) * 1994-07-14 1994-08-31 Glaxo Group Ltd Compounds

Also Published As

Publication number Publication date
WO2001062768A1 (en) 2001-08-30
US20010051612A1 (en) 2001-12-13

Similar Documents

Publication Publication Date Title
IL147198A0 (en) N-pyrazole a2a receptor agonists
IL147195A0 (en) C-pyrazole a2a receptor agonists
AU5203999A (en) Beta3-adrenergic receptor agonists
EP1255764B8 (en) Purine derivatives
AU2001284333A1 (en) Purine derivatives
AU6497701A (en) Melanocortin receptor agonists
AU4928101A (en) Spiropiperidine derivatives as melanocortin receptor agonists
HUP0401437A3 (en) Adenosine a3 receptor agonists
AU5640299A (en) 4-quinolinemethanol derivatives as purine receptor antagonists.(ii)
AU2001238665A1 (en) Method of identifying partial agonists of the a2a receptor
AU2001273032A1 (en) Cytokine receptor zcytor17
PT1192170E (en) PROPARGILFENILETER A2A RECEPTOR AGONISTS
AU2001278694A1 (en) Avermectin derivatives
AU2001247227A1 (en) 2-thioether a2a receptor agonists
AU2001241086A1 (en) Holder
AU2001223882A1 (en) Receptor
AUPQ563400A0 (en) Novel receptor
AU1252102A (en) Receptor
AU2001258432A1 (en) Z-crank mechanism
AU5257001A (en) Holder mechanism
AU2001272417A1 (en) G-protein coupled receptor org3.
AU2001294619A1 (en) Adp-glucose receptor
AU5895901A (en) Holder
AU2002215965A1 (en) Pyranoside derivatives
AU2001264045A1 (en) Dual purpose device